Xellar Biosystems develops a 3D Bio Intelligence platform combining organ-on-chip systems, laboratory automation, high-content imaging, multi-omics analysis, and AI-driven biological modeling.
The company focuses on creating human-relevant biological data infrastructure and virtual cell technologies to accelerate next-generation drug discovery.
Leadership & Board
Currently, no data available
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$50M
Total Amount Raised$50M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$50M
Latest Funding Amount$50M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jun 30, 2026
Series A
$50.00M
―
Similar Companies
A snapshot of private companies similar to Xellar Biosystems, helping you discover and navigate related company profiles.